All News

A recent study released by Cambium Analytica revealed FlackTek™ technology can effectively assist in the solvent purging process for cannabis extracts.

The discussion surrounding intoxicating the manufacture and sale of hemp-derived cannabinoids continues with more proposals and challenges.

Tilray’s Aphria RX obtained a cannabis trading license recently in Germany.

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

In reversal of recent developments, officials in Thailand have signaled that cannabis will not be re-criminalized.

The NCAA Division I Council recently voted to remove cannabinoids from their banned drug class for postseason football and NCAA championships.

A recently published study examined data on thousands of pregnancies, maternal health outcomes, and cannabis use.

Americans for Safe Access, a medical cannabis patient advocacy organization, held a briefing on the final day of the comment period for the proposed rulemaking on cannabis.

This article, originally published by our sister brand Nutritional Outlook, covered updates from the U.S. Food and Drug Administration and Federal Trade Commission on their jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Check out some of our most popular content from the first six months of the year 2024!

This latest episode of the monthly webinar series untangled the various aspects currently facing the US hemp industry.

Here, Scott Mazza, Founder of Vitality CBD, compares the effects of the cannabis compounds CBD and THC for use with various conditions.

The Senate’s latest attempt at legal medical cannabis access for patients was added to a bill on hemp regulations.

Let’s take a look at the most recent webinars on cannabis research and medicine to catch up on industry trends and innovations.

An executive order from the governor pardoned a significant number of cannabis convictions, noting the efforts to rectify harms from past cannabis policies.

This article, originally published by our sister brand LCGC International, summarizes an analysis and profiling of samples of illegal cannabis crops in Messina, Italy.

The smoking accessories company has partnered with the Science of Smokability study to advance research on cannabis smoking quality and consistency.

This month’s Healer webinar discussed several studies on cannabis and symptoms of dementia and cognitive decline.

This webinar discussed the research on the synergy of THC and D-limonene, discussing a study that found vaporized D-limonene reduces THC-induced anxiety.

Nebraska advocates are a few weeks away from knowing if two medical cannabis measures have enough signatures to qualify to appear on the 2024 ballot.

Three new positions were created to streamline and improve licensing processes, social equity, and more.

The new law eliminates the 37% excise tax for medical cannabis cardholders for certain products.

Willow Industries recently partnered with the Cannabis Research Coalition to advance cannabis research.

For the third time in recent years, the option to legalize recreational cannabis will be placed before voters in the Mount Rushmore State.

The Cannabis for Private Purposes Act legalizes cannabis for adults while prohibiting public consumption, sales, and detailing measures for protecting children.

A recently added amendment to the 2024 Farm Bill would significantly impact intoxicating hemp-derived products.

This webinar from MM411 explored the far-ranging studies of Dr. Raphael Mechoulam and Dr. Ethan Russo on the science and medicine of cannabis and other plants.